Nuvalent director awarded 3,444 RSUs

Bogle Grant C. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bogle Grant C. reported acquisition or exercise transactions in this Form 4 filing.

Nuvalent, Inc. director Grant C. Bogle received an equity award of 3,444 restricted stock units (RSUs) of Class A Common Stock. Each RSU represents one share of Class A Common Stock granted at $0.00 per share as compensation, not a market purchase.

The RSUs vest in full on the earlier of June 16, 2027 or Nuvalent’s next annual meeting of stockholders, as long as Bogle continues providing service through that date. After this award, Bogle’s direct holdings reported in this filing total 9,291 shares, including the RSUs.

Insider Trade Summary

Grant/Award: 3,444 shares

Grant/Award 1 txn

Insider Bogle Grant C.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	3,444	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 9,291 shares (Direct)

Footnotes (1)

1. F1. Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Key Figures

RSU grant size: 3,444 shares Grant price: $0.00 per share Holdings after transaction: 9,291 shares +1 more

4 metrics

RSU grant size 3,444 shares Restricted stock units representing Class A Common Stock

Grant price $0.00 per share Equity compensation award, not an open-market purchase

Holdings after transaction 9,291 shares Total direct Class A Common Stock including RSUs

RSU vesting date June 16, 2027 Vests on this date or earlier at next annual meeting

Key Terms

restricted stock units ("RSUs"), Class A Common Stock, annual meeting of stockholders

3 terms

restricted stock units ("RSUs") financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Class A Common Stock financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs")."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

annual meeting of stockholders financial

"The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nuvalent (NUVL) director Grant C. Bogle report?

Grant C. Bogle reported receiving 3,444 restricted stock units of Nuvalent Class A Common Stock as an equity award. The grant was recorded at $0.00 per share and is compensation-related, not an open-market stock purchase or sale.

How many Nuvalent (NUVL) shares does Grant C. Bogle hold after this Form 4?

After this award, Grant C. Bogle is reported as holding 9,291 shares of Nuvalent Class A Common Stock directly. This total includes the 3,444 shares issuable under the newly granted restricted stock units disclosed in the Form 4 filing.

When do Grant C. Bogle’s Nuvalent (NUVL) RSUs vest?

The 3,444 restricted stock units vest in full on the earlier of June 16, 2027 or the date of Nuvalent’s next annual meeting of stockholders. Vesting is conditioned on Bogle’s continued service to Nuvalent through the applicable vesting date.

What type of security was granted in this Nuvalent (NUVL) Form 4?

The filing reports restricted stock units representing Nuvalent Class A Common Stock. Each RSU entitles the holder to receive one share of Class A Common Stock upon vesting, aligning director compensation with the company’s equity performance over time.

Was cash paid for the Nuvalent (NUVL) RSU grant to Grant C. Bogle?

No cash was paid for this award; the 3,444 restricted stock units were granted at $0.00 per share. This reflects a stock-based compensation grant rather than an open-market purchase of Nuvalent shares by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bogle Grant C.

(Last) (First) (Middle)

C/O NUVALENT, INC.

ONE BROADWAY, 14TH FLOOR

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/16/2026		A		3,444(1)	A	$0.00	9,291	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

	/s/ Nathan McConarty, attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)